A lateral flow immuno-chromatographic assay for qualitative detection of antibodies indicative of Leishmania infection, built for simplicity and dependable performance.
Medzome is well-equipped to handle high-volume and institutional requirements, offering scalable supply, regulatory compliance, and operational efficiency.
